Cardiovascular Revascularization Medicine
Volume 9, Issue 3 , Pages 132-139, July 2008

Risk stratification after successful coronary revascularization☆☆

  • Masashi Goto

      Affiliations

    • Kyoto University Health Service, Yoshida-Honmachi, Sakyo-ku, Kyoto 606-8501, Japan
    • Corresponding Author InformationCorresponding author. Kyoto University Health Service, Yoshida-Honmachi, Sakyo-ku, Kyoto 606-8501, Japan. Tel.: +81 75 753 2400; fax: +81 75 753 2424.
  • ,
  • Shun Kohsaka

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA
  • ,
  • Noriaki Aoki

      Affiliations

    • University of Texas School of Health Information Sciences, Houston, TX 77030, USA
  • ,
  • Vei-Vei Lee

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA
  • ,
  • MacArthur A. Elayda

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA
  • ,
  • James M. Wilson

      Affiliations

    • Texas Heart Institute at St. Luke's Episcopal Hospital and Baylor College of Medicine, Houston, TX 77030, USA

Received 15 December 2007; received in revised form 16 March 2008; accepted 26 March 2008.

Abstract 

Background

Clinicians treating coronary revascularization patients need to be able to identify those who require more intensive medical therapy or follow-up. However, predictors of survival after coronary revascularization are often reported in terms of hazard ratios, which are accurate but difficult to convert to concrete values. We sought to develop a more practical and user-friendly method of predicting long-term survival in revascularization patients.

Methods

We used a decision-tree induction algorithm to retrospectively examine all-cause mortality during 3-year follow-up in 3331 consecutive patients with multivessel or single proximal left anterior descending coronary artery disease who underwent an isolated first revascularization by either coronary stenting or coronary artery bypass graft between 1995 and 1999.

Results

Recursive partitioning of the derivation cohort by the algorithm indicated that the best single predictor of long-term mortality was history of congestive heart failure, followed by age greater than 65 years and the presence of renal insufficiency. With these three variables, patients were readily stratified into low-, intermediate-, and high-risk groups whose 3-year mortality risks ranged from 2.0% to 18.8%. Logistic regression revealed nine significant predictors of 3-year mortality, including two interaction terms. Areas under the receiver operation characteristic curve for prediction of 3-year mortality were not significantly different between the decision tree and the logistic regression models [0.72 (95% confidence interval, 0.69 to 0.75) vs. 0.76 (95% confidence interval, 0.73 to 0.80)].

Conclusions

Long-term mortality risk in coronary revascularization patients can be estimated from three predictors that are easily obtained in clinical settings.

Keywords: Coronary arteriosclerosis, Myocardial revascularization, Prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was presented at the 7th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke in Washington, DC, on May 8, 2006.

☆☆ This study was supported by the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International (Tokyo, Japan). The authors have no potential conflicts of interest.

PII: S1553-8389(08)00121-8

doi:10.1016/j.carrev.2008.03.005

Cardiovascular Revascularization Medicine
Volume 9, Issue 3 , Pages 132-139, July 2008